Navigation Links
Stress On The Campaign Trail, One Issue All The Candidates Agree On
Date:3/24/2008

"I am confident that if we chose to give only one candidate a SpaCapsule(R), they would win hands down. One could easily compare the physical and mental results of the one who used the device, to the other two who did not."

Stress today is at an all time high, and all jokes aside, anyone can benefit from the SpaCapsule(R) experience, not just the Presidential candidates.

For more information visit the company website at http://www.spacapsule.com


'/>"/>
SOURCE Simulated Environment Concepts, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Does stress damage the brain?
2. Planning for Health Emergencies Eases Stress of Family Travel
3. Stress Can Help Trigger Stroke
4. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
5. Stress and fear can affect cancers recurrence
6. Brain stress system presents possible treatment
7. VIDEO from Medialink and Siemens: NFL Stars Stress the Importance of a Healthy Heart
8. New Scenic Relaxation Videos Help Reduce Stress, Promote Sense of Calm and Tranquility
9. Patients relatives are ignored by the health system and suffer emotional stress
10. Stress hormone impacts memory, learning in diabetic rodents
11. Stress may increase a womans risk of developing cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2Millions Flowing into Medical Real Estate 13292 1Millions Flowing into Medical Real Estate 13292 2Millions Flowing into Medical Real Estate 13292 3Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 1Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 2